Here are four automation best practices that can help any packaging line maximize their flexibility and productivity.

Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in accordance with ...

Yahoo Japan is taking a bold step by requiring all 11,000 of its employees to integrate generative AI into their daily work, aiming to double productivity by 2028. The company, which also operates ...

East Midlands Councils and Transport for the East Midlands have expressed dismay at the decision to ‘pause’ Midland Main Line ...

Trails Coalition recently awarded a contract to Asbell Construction, of Carl Junction, for the first phase of its plan to connect the Frisco Greenway and the Ruby Jack Trails. That first segment, just ...

"Equinor invests $1.2bn in Johan Sverdrup’s third phase to boost recovery" was originally created and published by Offshore Technology, a GlobalData owned brand.

Aker BP announces that the Johan Sverdrup partnership has made a final investment decision for Phase 3 of the field development. The project includes new subsea infrastructure that will increase ...

Metabolics Pharma Announces Positive Top-Line Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects ...

In interim analysis of phase 2 ASC2ESCALATE trial, patients with chronic-phase chronic myeloid leukemia who fail to respond to first-line therapies show major molecular responses to asciminib.

About Actuate-1801 Part 3B Study The Actuate-1801 Part 3B study (NCT03678883) is a randomized, controlled Phase 2 trial of elraglusib with GnP versus GnP alone in first-line mPDAC.

Already boasting a strong foothold in metastatic triple-negative breast cancer, Gilead Sciences’ Trodelvy has produced positive data that could make the antibody-drug conjugate part of a new ...

We conducted a phase 1a dose-finding trial of exercise therapy as first-line treatment for HR-positive advanced breast cancer (TBCRC 054). Methods: This multicenter trial was conducted using a patient ...